Phase IV Trial Assesses Cephalexin and Clavulanate Combination for Common Infections
A multicenter open-label trial evaluated oral extended-release cephalexin combined with clavulanate potassium for bacterial respiratory and skin infections.
A multicenter open-label trial evaluated oral extended-release cephalexin combined with clavulanate potassium for bacterial respiratory and skin infections.
The HIT-HARD trial protocol outlines a phase III study testing if short-course, high-dose beta-lactam therapy is non-inferior to conventional regimens ...
Two women's health studies presented at the Association for Molecular Pathology meeting show how molecular diagnostics reveal antibiotic resistance in ...
A cross-sectional study at Goba Referral Hospital in Ethiopia identified vancomycin-resistant Enterococci colonization in 6.7 percent of surveyed HIV-positive adults.
Combining the lytic bacteriophage MYY9 with meropenem curbed bacterial counts and alleviated acute lung infection caused by carbapenem-resistant Pseudomonas aeruginosa ...
A randomized trial indicates that rapid molecular testing in suspected ventilator-associated pneumonia increases early targeted therapy only in culture-confirmed cases ...
A genomic epidemiology study of 14 Neisseria meningitidis isolates from Shanghai and Guangzhou identified circulating urogenital lineages with international genetic ...
A prospective study in dogs with bacterial bronchopneumonia demonstrates that transtracheal wash cytology provides vital diagnostic confirmation of suppurative lower ...
A cross-sectional investigation in Maya City, Ethiopia, revealed an overall bovine mastitis prevalence of 38.8 percent alongside widespread Escherichia coli ...
A whole-genome sequencing and pangenomic analysis of Lactiplantibacillus plantarum JBC5 isolated from traditional Indian curd reveals robust metabolic, stress-tolerance, and ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine